ACADIA Pharmaceuticals Inc.
Price Action
Technical Summary
WEAKENINGACADIA Pharmaceuticals Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 47), showing significant lag compared to the market leaders. Earnings contraction of 82% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $21.40 | +1.03% | ABOVE |
| 50 SMA | $21.70 | -0.37% | BELOW |
| 100 SMA | $22.27 | -2.92% | BELOW |
| 150 SMA | $23.55 | -8.20% | BELOW |
| 200 SMA | $23.29 | -7.18% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ACAD in an uptrend right now?
ACAD has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is ACAD overbought or oversold?
ACAD's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is ACAD outperforming the market?
ACAD has a Relative Strength (RS) Rating of 47 out of 99. ACAD is currently lagging the broader market.
Where is ACAD in its 52-week range?
ACAD is trading at $21.62, which is 78% of its 52-week high ($27.81) and 24% above its 52-week low ($19.69).
How volatile is ACAD?
ACAD has a Beta of 1.08 and 52-week volatility of 38%. It's more volatile than the S&P 500 - expect bigger swings.